Counts and proportions of circulating leukocytes
| Parameter | Age of the patient at the time of the determination | Normal range | ||
| 19.0 yr | 19.3 yr | 19.6 yr | ||
| Polymorphonuclear neutrophils (/µl) | 3,600 | 4,200 | 2,400 | 1,500–3,500 |
| Lymphocytes (/µl) | 1,400 | 1,400 | 1,320 | 1,400–3,300 |
| Monocytes (/µl) | 500 | 500 | 280 | 210–730 |
| T cells (CD3+) (% lymphocytes) | ||||
| Total | 71.1 | 61.4 | ND | 67.5–77.8 |
| CD4+ | 38.9 | 32.2 | 31.2 | 26.8–42.7 |
| CD8+ | 21.3 | 17.7 | 18.4 | 22.1–36.8 |
| B cells (CD20+) (% lymphocyte) | 7.1 | 8.7 | ND | 8.0–18.3 |
| NK cells (CD3−CD56+) (% lymphocytes) | ||||
| CD56dim | 7.9 | 11.4 | ND | 3.5–12.3 |
| CD56bright | 0.29 | 0.26 | ND | 0.03–0.67 |
| NKT cells (CD3+Vα24+Vβ11+) (% CD3+ cells) | 0.17 | 0.32 | ND | 0.01–0.30 |
| γδ T cells (CD3+Vγδ+) (% CD3+ cells) | 7.9 | 15.7 | ND | 2.4–6.77 |
| Parameter | Age of the patient at the time of the determination | Normal range | ||
| 19.0 yr | 19.3 yr | 19.6 yr | ||
| Polymorphonuclear neutrophils (/µl) | 3,600 | 4,200 | 2,400 | 1,500–3,500 |
| Lymphocytes (/µl) | 1,400 | 1,400 | 1,320 | 1,400–3,300 |
| Monocytes (/µl) | 500 | 500 | 280 | 210–730 |
| T cells (CD3+) (% lymphocytes) | ||||
| Total | 71.1 | 61.4 | ND | 67.5–77.8 |
| CD4+ | 38.9 | 32.2 | 31.2 | 26.8–42.7 |
| CD8+ | 21.3 | 17.7 | 18.4 | 22.1–36.8 |
| B cells (CD20+) (% lymphocyte) | 7.1 | 8.7 | ND | 8.0–18.3 |
| NK cells (CD3−CD56+) (% lymphocytes) | ||||
| CD56dim | 7.9 | 11.4 | ND | 3.5–12.3 |
| CD56bright | 0.29 | 0.26 | ND | 0.03–0.67 |
| NKT cells (CD3+Vα24+Vβ11+) (% CD3+ cells) | 0.17 | 0.32 | ND | 0.01–0.30 |
| γδ T cells (CD3+Vγδ+) (% CD3+ cells) | 7.9 | 15.7 | ND | 2.4–6.77 |
Normal range values are from five age-matched healthy controls.